Dilantin Toxicity
Neurol 11:912-922, Roseman,E., 1961
Risk Factors of Hyperammonemia in Patients with Epilepsy Under Valproic Acid Therapy
Medicine 93:e66, Tseng, Y.L.,et al, 2014
A Systematic Review of Antiepilpetic Drug Initiation and Withdrawal
The Neurologist 15:122-131, Shih,J.J &Ochoa,J.G., 2009
Generalized Tonic-Clonic Seizures After Acute Oxcarbazepine Withdrawal
Neurol 70:2187-2188, Azar,N.J.,et al, 2008
Tiagabine-Induced Myoclonic Status Epilepticus in a Nonepileptic Patient
Neurol 68:310, Vollmar,C. &Noachtar,S., 2007
Carbamazepine Encephalopathy Masquerading as Creutzfeldt-Jakob Disease
Neurol 65:650-651, Horvath,J.,et al, 2005
Protein C Deficiency Related to Valproic Acid Therapy: A Possible Association with Childhood Stroke
J Pediatr 137:714-718, Gruppo,R.,et al, 2000
Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999
Valproate-Induced Coma with Ketosis and Carnitine Insufficiency
Arch Neurol 47:1131-1133, Triggs,W.J.,et al, 1990
Withdrawal Symptoms from Phenytoin, Carbamazepine and Sodium Valproate
JNNP 51:924-928, Duncan,J.S.,et al, 1988
Valproic Acid, Review of a New Antiepileptic Drug
Arch Neurol 36:393-398, Bruni,J.,et al, 1979
Acute Intoxication with Sodium Valproate
Ann Neurol 6:552-553, Chadwick,D.W.,et al, 1979
Phenytoin-induced Ophthalmoplegia
Neurol 26:1031, Spector,R.H.,et al, 1976
Diphenylhydantoin Activated Seizures
Neurol 15:716-722, Levy,L.L.,et al, 1965
Unusual Brain Syndrome Seen with Diphenylhydantoin & Phenobarbitol
Am J Psych 120:282-283, Hoaken,P.C.S.,et al, 1963